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Objectives: to investigate the presence of Chlamydia pneumoniae in the wall of abdominal aortic aneurysms (AAAs)
and in the aortas of patients without a history of cardiovascular disease.
Design: case–control study.
Materials: twenty-six consecutive patients operated for AAA were compared to 17 controls.
Methods: aorta was obtained at surgery or autopsy (controls) and prepared for immunohistochemical (IHC) analysis
and culture for C. pneumoniae. Throat swabs from 14/26 patients were analysed by PCR for C. pneumoniae. Blood
was obtained from 24/26 patients and from 178 70-year-old males.
Results: C. pneumoniae was detected in the aortic aneurysms of 20/26 patients by IHC. C. pneumoniae was cultured
from 10 of the 20 IHC-positive patients. Only 1/17 controls was positive for C. pneumoniae by IHC (p=0.0001). PCR
was positive for C. pneumoniae in 5/14 patients. Serological analysis by microimmunofluoresence (MIF) showed
significantly more high titres of the specific antibodies to C. pneumoniae in patients than in age-matched male controls.
Conclusions: we conclude that C. pneumoniae is often present in AAAs in a viable form and that C. pneumoniae is
linked to the pathogenesis of AAA.
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Introduction pneumoniae with coronary heart disease, a number
of investigations have confirmed this finding.12–15 C.
The pathogenesis of abdominal aortic aneurysms pneumoniae has been detected in the abdominal aorta16
(AAAs) is still not fully understood, but involves a and in the coronary, carotid and iliac arteries16–22 by
variety of complex interacting factors. The abdominal immunohistochemistry (IHC) and PCR techniques. C.
aortic aneurysm (AAA) is formed over several years pneumoniae has been cultured from the carotid artery20
and is characterised by weakening and dilatation of and from the coronary artery of an explanted heart,22
the aortic wall. AAAs are characterised by a marked indicating that the organism is metabolically active.
inflammatory infiltrate throughout the aortic wall1,2,3 Some studies suggest that there is a genetic element
and a positive correlation has been shown between involved in the aetiology of AAA23 and that there may
elastolytic activity and invasion of the aortic wall by be a dominance of certain HLA-DR antigens.24 Other
white blood cells.2,4 The UK Small Aneurysm Trial5 reports indicate that AAA is caused by an autoimmune
has indicated that the growth of aneurysms is as- reaction.25 Recently, investigators found an association
sociated with an increased concentration of in- of a 60 kD protein suggesting that Chlamydia sp. may
flammatory cells in the adventitia, the dominating cells cause vascular damage by means of antigenic mimicry,
being macrophages and B-cells.6 Activated macro- triggering autoimmune reactivity.26
phages appear to play a crucial role through their We present an investigation of consecutive patients
production of elastase in AAA.7 operated on for AAA between March and December
Chlamydia pneumoniae is a common cause of acute8 1998 at our hospital. Aortic tissues from age-matched
and chronic respiratory tract infections.9,10 Since 1988, autopsies of patients without previous known cardio-
when Saikku et al.11 first reported an association of C. vascular disease were used as controls for IHC, and a
group of 70-year-old men with and without history
of cardiovascular disease were used as controls for∗ Please address all correspondence to: L. Karlsson, Department of
Surgery, Ga¨vle-Sandviken Central Hospital, S-801 87 Ga¨vle, Sweden serology.
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Materials and Methods diseases were used as controls for IHC. All had a
macroscopically normal appearance. A total of 178 70-
Ga¨vle Central Hospital is the main hospital of the year-old male individuals selected at random for a
population study28 were analysed regarding the pre-county, serving a population of 290 000. A longitudinal
epidemiologic study has indicated that there were at valence of humoral-specific antibodies of the IgG, IgM
and IgA classes to C. pneumoniae by micro-least two largely subclinical epidemic waves of C.
pneumoniae infection between 1990 and 1996.27 immunofluorescence as described earlier.9,10,27 The in-
dividuals were divided into one group with a history
of myocardial infarction (n=18) and another without
Patients (n=160). These patients have recently been described.28
All patients operated for AAA at the Ga¨vle Central
Hospital from March through December 1998 were
Methodsincluded in the study. Twenty-six consecutive patients
(25 M, 1 F) with an infrarenal abdominal aortic an-
C. pneumoniae serologyeurysm underwent surgery. The indications for sur-
gery were aneurysm size larger than 5 cm in diameter
Sera were analysed for C. pneumoniae IgG, IgA and IgM(one 4.8 cm), rupture, or symptoms. Eight of the pro-
antibodies by microimmunofluorescence according tocedures were emergency cases, five were symptomatic
a method described earlier.9,10 All fluorescein-con-and 13 (12 M, 1 F) were elective procedures. None of
jugated antibodies were obtained from Dako (Dako-the aneurysms had the macroscopic appearance of
patts, Denmark) and antigen slides were obtained frominflammation. Four out of 26 had a history of AAA
Lab Systems (Lab Systems Oy, Helsinki, Finland).among close relatives. Ten of 26 had never smoked or
Incubation of antigen and serum dilutions was donehad quit smoking >10 years ago. No patient was
overnight (16–18 hours) at+4°C. All specimens foundtaking medication for hyperlipidaemia and no lipid
to contain IgA on screening were diluted in GullSorbabnormality was detected in the 22 patients in-
(Gull Laboratories, U.S.A.) to remove possible in-vestigated. Two of the patients were brothers. The
terference from IgG and re-titrated.median age of the patients was 76 years (range 63–86).
A segment of the aorta, resected during surgery,
was immersed in 2 SP (sucrose phosphate buffer – a
Chlamydia transport medium) and immediately trans- PCR
ported to the microbiology laboratory for analysis. The
specimens were aseptically divided into several pieces Specimens were taken from the retropharyngeal wall
to provide material for culture after homogenisation of with CTA (Chlamydia trachomatis aluminium) swabs
the tissue. Another segment was immersed in formalin and immersed in 2 SP. Specimen preparation was done
and analysed by immunohistochemistry (IHC) (see using the Roche Respiratory Specimen Preparation
below). The samples were either cultured immediately Kit (Roche Diagnostic Systems Inc., Branchbury, NJ,
or frozen after homogenisation at −70 °C at the U.S.A.) as described earlier.29 The primers used for
laboratory, except for the tissues taken during emer- PCR were HR-1 and HL-1 according to Campbell et
gency operations, which were kept for up to 8 hours al.30 Amplification products in agarose gel with added
in 2 SP at +4–8 °C. ethidium bromide were visualised after electro-
Serum specimens were obtained during the hospital phoresis on an UV transilluminator.
stay for analysis of humoral antibodies to C. pneumoniae
from 21 of the 26 patients. Throat specimens were
taken from 14 of the 25 male patients for analysis of
C. pneumoniae cultureC. pneumoniae by polymerase chain reaction (PCR).
Blood was obtained later for analysis of HLA antigens
Aortic homogenates were thawed at room temperaturefrom 21 of the patients.
and 0.5 ml was layered on Hep-2 cell monolayers. The
cell culture medium used was RPMI 1640 (Sigma
Chemical Co., St. Louis, MO, U.S.A.) with 2% fetalControls
bovine serum, glutamine, netilmycin, vancomycin and
fungizone. The inoculated cultures were centrifugedPieces of abdominal aorta from age-matched patients
who had died from other causes than cardiovascular at 800× g for 60 min and, after introduction of 0.5 ml
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of new medium, incubated with 5% CO2 for 3 days. IgG titres of [512 and 2/5 had IgA titres of [64. Six
of nine PCR-negative patients had a specific IgG titreSpecimens were passaged a minimum of four times
before staining with a genus-specific Chlamydia mono- of [512 and 6/9 had IgA titres [64. The Arithmetric
Mean Titres of IgG and IgA were lower in patientsclonal (Kallestad, Chaska, MN, U.S.A.). A minimum of
10 passages was done for each specimen. All specimens PCR-positive from throat specimens than patients with
negative PCR (IgG 627 vs. 1230; IgA 83 vs. 238). Onlyfound to be positive in culture were recultured using
a new aliquot of the homogenates frozen at −70 °C. 2/10 culture-positive patients had a positive PCR test
from throat swabs. One patient was positive by PCR
from the throat swab but negative in IHC and culture
of aorta. Serologic markers for C. pneumoniae infection
Immunohistochemistry were detected in 19/21 patients sampled. High titres
of specific IgG antibodies (titres [512) and IgA (titres
The aortic tissues were fixed in 4% formalin and [64) to C. pneumoniae at the time of operation were
paraffin-embedded at the pathology laboratory. Three- found and are shown in Table 1 with results from the
to four-m sections were cut and placed on microscope 70-year-old men. As no difference was detected in
slides (Plus Glas, Histolab, Gothenburg, Sweden). antibody titres between controls with a history of
Slides were heat-treated at 60 °C for 45 min to facilitate myocardial infarction (n=18) and those without (n=
binding of tissue to slides, and tissue sections were 160), all controls were grouped together.
deparaffinised before staining. All tissue sections were HLA typing done on 21 of the 26 patients did
treated with a 0.5% pepsin solution (Sigma Chemical not reveal any significant differences from a normal
Co., St. Louis, MO, U.S.A.) adjusted to pH 2.0 with 1 M population regarding the detected haplotypes (data
HCl, after which they were treated with a peroxidase not presented). The two brothers with AAA had dif-
blocking reagent (Dako, Denmark). Staining was done ferent haplotypes.
with the StreptABC Complex/HRP Duet (Dako) ac-
cording to Hsu´31 using a mouse-derived C. pneumoniae
monoclonal generously donated by Dr. Kenneth Per-
Discussionsson, Malmo¨. This monoclonal had earlier been com-
pared with RR-402 (Dako, Denmark) and found to
In this pilot study we have been able to demonstratehave an identical antigenic specificity and binding
the presence of C. pneumoniae in a majority of patientsproperties. The monoclonal was tested against C. trach-
with AAA undergoing surgery. A high proportion ofomatis and did not stain this closely related organism.
these patients were found to have specific IgG and/Negative controls on the staining procedure were in-
or IgA antibody titres which may reflect chronic in-cluded for each tissue sample by exchanging the mono-
fection,9,10,12,14,34 as compared to a control population.clonal antibody for PBS.
A high number of patients with AAA were positive
for C. pneumoniae by immunohistochemistry of aortic
samples as compared to control aortas derived from
autopsy material with a macroscopically normal ap-Results
pearance. Isolation of viable C. pneumoniae was possible
in more than 40% of these patients with AAA.Twenty of the twenty-five aortic samples from the
male patients were positive by IHC for C. pneumoniae PCR was done on throat swabs in an attempt to
determine carriage of C. pneumoniae in this patient(80%). The aorta from the female patient was also
positive. C. pneumoniae-containing cells were detected group. The finding of C. pneumoniae in the throat was
not found to have a direct relationship with the findingin areas demonstrating an invasion of inflammatory
cells, mainly macrophages and lymphocytes (see Fig. of bacteria in the aortic wall. We have similar findings
in an earlier investigation of patients with acute myo-1a–d). C. pneumoniae was detected by IHC in only one
of the seventeen controls (p=0.0001). cardial infarction or chronic coronary disease where
throat carriage was not related to cardiovascularC. pneumoniae was cultured on two separate oc-
casions from different aortic tissue portions which had events.13
The methodology used for this study has been wellbeen kept frozen at −70 °C from 10 of the 25 male
patients. None of the specimens negative by IHC were established and evaluated in other populations.9,10,27
In our laboratory, serology using the cut-off limitspositive in culture. PCR specimens from the throat
were positive for C. pneumoniae in 5/14 patients. Four IgG[512 and IgA[64, has previously been shown to
be associated with existing chronic infection.9,10,15 Theof five PCR-positive patients had specific C. pneumoniae
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Fig. 1. Sections of normal aorta and of abdominal aortic aneurysm with C. pneumoniae. (a) Normal aorta, ×100. (b) Normal aorta, ×400.
Cross-section of arteriole in aortic wall. (c) Abdominal aortic aneurysm, ×100. Note abundance of inflammatory cells. (d) Abdominal
aortic aneurysm, ×400. Cross-section of arteriole in aortic wall with inflammatory infiltrate and macrophage-like cell containing C.
pneumoniae.
Table 1. High specific antibody levels of IgG and of IgA to C. of the bacterium.32 However, it is intriguing that 80%
pneumoniae in patients with AAA and in 178 70-year-old controls of the AAA patients had both microbiological and/or(%).
histological signs of ongoing C. pneumoniae infection
AAA Controls in the aortic wall. It should be noted that since all
cultures for C. pneumoniae were performed in duplicaten 21 178
on different occasions, using stringent conditions toMedian age 74 70
IgG[512 16/24 (67) 47/178 (26.4) prevent cross-contamination of cultures, all the du-
IgA[64 14/24 (58) 55/178 (30.9) plicate cultures showed similar results and only IHC-
positive tissues gave rise to positive cultures. Thus,AAA/controls IgG[512: p<0.0002; OR 5.57 (2.07–15.34).
AAA/controls IgA[64: p=0.015; OR 3.13 (1.21–8.17). it is unlikely that the positive cultures are due to
contamination during the cultivation procedure. Cul-
control population used for serology had a slightly ture of C. pneumoniae from aortic tissues was difficult,
lower mean age than the AAA population, but this is necessitating multiple passages (between 4 and 9)
not sufficient as an explanation for the significant to obtain cultures with a confluent growth of the
differences in antibodies found in the two groups. organism.
Antibodies produced as a marker for stimulation of Chlamydia pneumoniae infection has traditionally
the immune response are prevalent in patients with been associated with acute respiratory infection. Over
the last few years both seroepidemiological studieschronic infection irrespective of the tissue localisation
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and studies of atherosclerotic lesions throughout the tributes to aneurysm formation or whether the in-
fection is secondary to a pre-existing aneurysm.arterial tree have revealed associations between signs
of Chlamydia infection and atherosclerotic lesions in
cardiovascular disease (for review, see ref. 14). A C.
pneumoniae infection in the respiratory tract may
Referencesspread systemically by means of phagocytosis of the
bacteria in the lungs by alveolar macrophages. C.
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